(Reuters) -Lenz Therapeutics said on Wednesday its lead experimental drug being tested in patients with a common age-related eye disorder showed improvement in nearsightedness in a […]

(Reuters) -Roivant Sciences’ experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm’s shares […]

You can’t spell “ophthalmologist” without artificial intelligence (AI) — a fact that might have many eye specialists looking warily over their shoulders. But should they be […]

This month, the European Medicines Agency (EMA) gave marketing authorization to bevacizumab-vikg (Lytenava, Outlook Therapeutics) for the treatment of neovascular (wet) age-related macular degeneration (AMD). The […]

TOPLINE: Vision impairment is associated with increased risks for social isolation and symptoms of depression and anxiety among older adults in the United States, new research […]

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending that patients being treated for visual impairment caused by chronic diabetic […]

A diagnostic approach that clusters multiple tests of visual field and retinal imaging in an intense 6-month period has demonstrated the potential to identify patients likely […]

A large international, multicenter study has shown that creating a full-circumference incision around the trabecular meshwork to lower intraocular pressure (IOP) in open-angle glaucoma, a procedure […]